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Abstract: The human genome encodes nine functional voltage-gated Na
+ channels. Three 
of them, namely Nav1.5, Nav1.8, and Nav1.9, are resistant to nanomolar concentrations of 
tetrodotoxin (TTX; IC50 ≥ 1 µM). The other isoforms, which are predominantly expressed 
in the skeletal muscle and nervous system, are highly sensitive to TTX (IC50 ~ 10 nM). 
During the last two decades, it has become evident that in addition to the major cardiac 
isoform Nav1.5, several of those TTX sensitive isoforms are expressed in the mammalian 
heart. Whereas immunohistochemical and electrophysiological methods demonstrated 
functional expression in various heart regions, the physiological importance of those 
isoforms for cardiac excitation in higher mammals is still debated. This review summarizes 
our knowledge on the systemic cardiovascular effects of TTX in animals and humans, with 
a special focus on cardiac excitation and performance at lower concentrations of this 
marine drug. Altogether, these data strongly suggest that TTX sensitive Na
+ channels, 
detected more recently in various heart tissues, are not involved in excitation phenomena in 
the healthy adult heart of higher mammals.  
Keywords: Na
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1. Introduction 
Voltage-gated sodium (Na
+) channels are responsible for the fast upstroke of action potentials in 
electrically excitable cells [1]. These channels form heteromultimeric proteins consisting of a large 
pore-forming α subunit and small accessory β subunits. Ten different α and four β subunit isoforms 
have been cloned from different mammalian tissues [2]. The Na
+ channel isoform Nav1.5, encoded by 
the SCN5A gene, is the predominant α subunit in the heart and plays a key role in the excitability of 
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atrial and ventricular cardiomyocytes and in rapid impulse propagation through the specific conduction 
system [1–5]. Mutations in SCN5A can cause a broad variety of pathophysiological phenotypes, such 
as long QT syndrome type 3 (LQT3), Brugada syndrome (BrS), cardiac conduction disease (CCD), 
and sick sinus syndrome (SSS) [6,7]. 
Cardiac Nav1.5, as well as Nav1.8 and Nav1.9 channels, which are both expressed in dorsal root 
ganglion neurons, are resistant to nanomolar concentrations of the pufferfish poison tetrodotoxin 
(TTX). The IC50 is equal or higher than 1 µM [2,8]. In contrast to the cardiac isoform, neuronal and 
skeletal muscle Na
+ channels are highly sensitive towards TTX (IC50 ~ 10 nM) [2,8]. The TTX 
sensitive (TTXs) Na
+ channels are: (a) Nav1.1, Nav1.2 and Nav1.3, which are highly expressed in the 
central nervous system, (b) Nav1.4, the predominant Na
+ channel in skeletal muscle, (c) Nav1.6, widely 
expressed in neurons of the central and peripheral nervous system, and (d) Nav1.7, which is found in 
the peripheral nerve system including sympathetic fibers [2]. 
2. TTX Sensitive Na
+ Channels in the Mammalian Heart—A Brief Summary 
During the last two decades, several electrophysiological and biochemical studies have explored the 
molecular nature of the cardiac Na
+ current, thereby providing strong evidence in support of the 
expression of skeletal muscle and neuronal Na
+ channels in the mammalian myocardium (Table 1, 
reviewed in [9]). Results were obtained using in vitro assays, such as expression pattern analysis by 
RT-PCR or protein analysis by Western blotting and immunofluorescence. Using electrophysiological 
techniques on isolated cardiomyocytes, several authors succeeded in demonstrating an often small Na
+ 
inward current that could be blocked at nanomolar concentrations of TTX. One study even suggested 
that the plasma membrane of the middle portion of rabbit ventricular cardiomyocytes contains 
exclusively TTXs Na
+ channels [10]. Based on RNA/protein detection methods and on 
electrophysiological measurements at nanomolar concentrations of TTX (see Table 1), enthusiastic 
discussions and far-reaching speculations on the function of these channels were published [9,11,12]. 
However, conflicting results were reported (see Section 5), and moreover, a convincing evidence for 
an important physiological role of TTXs Na
+ channels in the adult myocardium of higher mammals 
was not yet provided. 
I thought that if TTXs Na
+ channels exert direct chronotropic, inotropic, and dromotropic effects in 
the normal heart, one should observe, first, diminished cardiac conduction and output in animals 
intoxicated with low, i.e., sub-lethal doses of TTX, and second, impaired cardiac performance in 
accidentally intoxicated humans. This review summarizes the literature on both aspects. Particular 
attention is paid to the systemic effect of TTX on cardiovascular functions of higher mammalian 
animals. The answer to the question, whether or not TTXs Na
+ channel transcripts and proteins are of 
any physiological relevance in the normal heart, could help us to better understand basic cardiac 
excitation phenomena. Moreover, it could be important for the development and application of 
antiarrhythmic drugs, for the clinical management of cardiac diseases, and even for emergency 
physicians treating TTX-poisoned patients. Mar. Drugs 2010, 8                 
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Table 1. Suggested functions of TTXs Na
+ channels in the mammalian myocardium. A 
detailed overview on tissue distribution and detection methods for the individual TTXs Na
+ 
channels was given by Haufe et al. [9]. 
Study  Results and suggested function of TTXs Na
+ channels  Species 
  Sinus node automaticity and control of heart rate   
[13,14] Nav1.1 transcripts and TTXs currents (IC50 ~ 26 nM) in newborn (but not adult)  
sinus node cells, suggesting that, depending on age, TTXs Na
+ channels contribute 
to slow diastolic depolarization. 
Rabbit 
[12]  Reduction in spontaneous heart rate by blocking Nav1.1/Nav1.3 at 100 nM TTX; 
important contribution of TTXs Na
+ channels to sinus node automaticity and rhythm, 
suggesting a possible contribution to SSS in man. 
Mouse 
[15]  Slowing of pacemaking in intact sinus node preparations and isolated cells at  
10 and 100 nM TTX, slowing of both pacemaking and sinus node conduction 
at 1–30 µM TTX. 
Mouse 
  Efficient EC coupling and increased cardiac contractility   
[11]  Reduction of left ventricular function at 100 and 200 nM TTX, suggesting an 
unexpected role of brain-type Na
+ channels in excitation-contraction coupling. 
Mouse, 
guinea pig 
[16]  Localization of brain-type Na
+ channels and two β subunits in transverse tubules 
of myocytes, suggesting AP propagation from the cell surface into the interior 
by defined α/β-channel complexes. 
Mouse 
  Purkinje fibers: Efficient cardiac conduction and AP prolongation   
[17]  Shortening of AP duration, but not of the maximum rate of rise, at low TTX (≥33 nM).  Dog 
[18]  Higher transcript levels and TTXs currents in Purkinje fibers (35 and 22%), when 
compared to ventricular myocytes (<20 and 10%, respectively). 
Dog 
[19]  Expression of Nav1.4 in cardiac Purkinje myocytes (PCR, immunofluorescence).  Dog 
  Other reports   
[20]  Detection of Nav1.1 transcripts in the heart.  Rat 
[21] Cardiac  Na
+ channels are composed of either Nav1.1 or Nav1.5, and both 
associate with β1 and β2. 
Mouse, rat 
[22]  Up-regulation of Nav1.1 and increased TTXs Na
+ current in the postinfarction 
remodeled myocardium. 
Rat 
[5,23]  Large transcript pool in whole hearts (30–40%), smaller TTXs Na
+ currents in  
ventricular myocytes (8%) of mice (not observed in pigs and humans). 
Mouse 
[10]  Middle region of ventricular myocytes contains only TTXs Na
+ channels,  
that can be blocked by 50 nM TTX. 
Rabbit 
[24]  Prolongation of the cycle length of the spontaneous pacemaker activity at 100 nM TTX 
by 22% and 53% in sinoatrial and atrioventricular node preparations, respectively. 
Mouse 
3. Systemic Effects of TTX on the Cardiovascular System—Lessons from Animal 
Experimentations 
The first extensive scientific studies on TTX poisoning, published in a western language, appeared 
at the end of the 19th and beginning of the 20th centuries [25–27]. The authors fed several different 
mammalian species with pufferfish viscera or, as in most cases, injected purified toxin extracts from Mar. Drugs 2010, 8                 
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hard roe subcutaneously. They determined the minimal lethal dose (MLD) and meticulously described 
systemic effects and dysfunction of most organs at varying toxin dosages. Later, cardiovascular effects 
of TTX were intensively studied from the mid 50s to the early 70s, when TTX was commercially 
available as a highly purified powder and when its chemical structure was identified [28]. In the last  
30 to 40 years, research into the systemic effects of TTX in mammals faded again from the scientific 
spotlight and relatively few articles appeared. 
There are some limitations regarding these previous reports that have to be mentioned: Firstly, 
animal models of cardiac diseases were not considered, but the presumed cardiac TTXs Na
+ channels 
could play a role in the diseased heart. In the ischemic and reperfused myocardium, a TTXs persistent 
Na
+ current component (INa(P)) is characteristically increased, which may trigger afterdepolarizations 
and life-threatening arrhythmias (reviewed in [29]). The molecular nature of this pathologically 
enhanced INa(P) is not entirely clear [29]. This current fraction could be either caused by a specific 
gating mode of Nav1.5 [30,31] or by non-inactivating neuronal Na
+ channels (reviewed in [9]). 
Notably, Nav1.1 was upregulated in a rat infarct model and concomitantly prolonged action potentials 
could be shortened by 100 nM TTX [22]. Furthermore, it is possible that upregulation or modulation of 
TTXs Na
+ channels preserves cardiac conduction under hypoxic/ischemic conditions, because steady-
state inactivation in TTXs Na
+ channels is positively shifted, compared to Nav1.5 [9,32]. 
Consequently, TTXs Na
+ channels would be available in a respectively depolarized myocardium, 
thereby safeguarding cardiac conduction [9,32]. Secondly, only adult animals were used, but TTXs 
Na
+ channels may be subject to developmental regulation in the heart [5,13,23,33,34]. Thirdly, there 
were no systematic studies on possible gender differences [5]. Several previous studies included both 
male and female animals. A significant difference was not reported [35–40]. Fourthly, mice were often 
used to estimate the lethality of a TTX solution, but the reaction of their cardiovascular system to 
intoxication was not or rarely investigated. In contrast to higher mammals, mice may require a high 
density of TTXs Na
+ channels in their sinus node and ventricles to maintain the extremely high heart 
rate and the resulting fast conduction. Fifthly and most importantly, effective toxin concentrations, as 
well as the distribution and fate of TTX in the body, often remained uncertain. The toxin was given 
orally, intravenously (i.v.), subcutaneously (s.c.), intraarterially (i.a.), or intraperitoneally (i.p.). Blood 
or urine levels of TTX were not systematically investigated. It is known that TTX distributes nearly 
everywhere in the body fluid [41], but significant concentration differences may exist between the 
organs. In one study, highest concentrations were found in rat kidney and whole heart, lowest 
concentrations in brain and blood [41,42]. The half-time of disappearance of the toxin after 
subcutaneous injection varied from 30 minutes to four hours, depending on the organ [42]. 
Despite these uncertainties, the systemic application of TTX seems to be superior to most of the 
more recently applied in vitro approaches (Table 1), because TTX acts on Na
+ channels in their natural 
environment and at physiologic membrane potentials. For example, TTXs Na
+ channels might be 
detectable in vitro, but they could be actually unavailable for excitation in vivo. Thus, they could be 
physiologically irrelevant for normal cardiac function. Concerning the effective toxin concentration, 
one can assume that TTX doses used in previous studies were high enough to block the vast majority 
of the presumed functional TTXs Na
+ channels in the adult mammalian heart: Firstly, injecting one 
MLD, equivalent to 5–10 µg/kg (see Table 2), and assuming a uniform distribution in the extracellular 
space, the effective TTX concentration should be nearly 80–160 nM [37]. Toxin dilution on the way to Mar. Drugs 2010, 8                 
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the heart should be much less pronounced, when injecting the drug bolus i.v. within a few seconds 
[43]. For example, application of 0.5–1.0 MLD into the jugular vein within seconds could result in 
such a high TTX concentration in the heart that already blocks a portion of Nav1.5 channels. Secondly, 
TTX at large sub-lethal doses resulted in severe impairment of many neurological/neuromuscular 
functions that are all controlled by TTXs Na
+ channels. Symptoms are urination, hypersalivation, 
retching, vomiting, diarrhoea, diminution or absence of reflexes, skeletal muscle fasciculations, 
lethargy, ataxia, ascending progressive paralysis, respiratory pattern changes, and dyspnoea 
[35,36,41,44]. Death is due to a rather complex action of TTX on the respiratory system, involving 
blockade of the phrenic nerve, the diaphragm and neurons in the central respiratory   
network [26,27,36,41,45].  
Most, if not all, investigators excluded direct TTX-specific cardiac irregularities. Their studies 
provided overwhelming evidence that the heart belongs to the very few organs that remain nearly 
unaffected, even at large sub-lethal or lethal TTX doses. Note that intoxication often required artificial 
ventilation, but the heart continued beating regularly [37–41,44,46,47]. Nevertheless, TTX exerts 
pronounced depressive effects on the circulatory system (Table 2). Cardiovascular reactions of 
intoxicated animals are a reduced blood pressure (3.1), bradycardia (3.2), and in few cases, reduced 
ventricular force and stroke volume (3.3). Conduction disturbances occurred rarely and were often 
characteristic of a severe TTX intoxication (3.4). In the following sections, the mechanisms for these 
cardiovascular reactions are summarized and discussed. 
3.1. Hypotension 
Reduction in arterial blood pressure can result from a reduced total peripheral resistance (TPR) 
and/or a reduced cardiac output. Already in 1890, Takahashi and Inoko concluded that the heart does 
not contribute to the TTX-mediated blood pressure reduction [26]. The authors explained the 
hypotensive action of the toxin exclusively with a reduced vasomotor tone, resulting in a significant 
TPR reduction. Compression of the abdominal aorta or volume expansion instantaneously normalized 
a markedly lowered carotid blood pressure and a slightly lowered pulse rate in TTX-poisoned cats and 
dogs [26]. A direct negative inotropic or chronotropic action of TTX in intoxicated animals was 
excluded also in most if not all subsequent studies. For example, Cheng and colleagues [43,46] found 
that the blood flow in the ascending aorta was not measurably altered when injecting a dose of   
0.25 MLD into right external jugular vein (Table 2), demonstrating that the simultaneously observed 
arterial hypotension was caused by peripheral vasodilatation only. 
The mechanisms behind the TTX-mediated vasodilatation were investigated by several groups. The 
significance of each mechanism, however, was discussed controversially [39,41]. Firstly, TTX could 
act on medullary structures known to be involved in cardiovascular control after the toxin crossed the 
blood-brain barrier [26,27,35,36,41,45]. Hypotension occurred nearly instantaneously when low doses 
of TTX were injected into the brain or carotid artery of cats and rats [35,48]. In another study, a fast 
vasodepressive response and a delayed but significant bradycardia was observed when 12.5–25 pmol 
TTX were injected into the cat nucleus reticularis lateralis (NRL), a ventromedullary vasopressive 
region [40]. Microinjection of the same TTX dose into the nucleus tractus solitarii (NTS), a well 
known vasodepressive and cardio-inhibitory area, caused an increase in blood pressure. Secondly, Mar. Drugs 2010, 8                 
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vasodilatation resulted mainly from a conduction block in sympathetic fibers [27,35,37,39,41,43,46]. 
Thirdly, low doses of TTX may directly affect vascular smooth muscles [39]. Several authors, 
however, did not observe any effect of TTX on smooth muscle tone [27,37,43].  
Table 2. In vivo effect of TTX on the cardiovascular system of various mammalian 
species. Only studies with a strong focus on the cardiovascular system were included. The 
minimal lethal dosages (MLD), applied i.p. or i.v., were 2.7–10 µg/kg for rats [41,43],  
4.5 µg/kg for guinea pigs [41], 8–10 µg/kg for mice, rabbits, dogs, and cats [35,36,41,49]. 
Neuromuscular function was already severely affected at sub-lethal dosages. Given orally, 
the MLD in cats, but not in humans (see Section 4), was at least 20-times higher [35]. 
Study  Species  TTX app-lication  TTX dose  Cardiovascular effects 
[26]  dog, cat, 
rabbit, 
rat 
s.c.  Tetrodon hard 
roe extracts 
mild intoxication: ataxia and paresis at normal 
heart function and blood pressure 
severe intoxication: cyanosis, areflexia, respiratory 
arrest, hypotension, bradycardia, AV block 
[27]  rabbit 
bufo 
i.v. 
s.c. 
≥0.7 MLD  hypotension, SA and AV block, but no direct 
chronotropic or inotropic effects 
[47]  dog  into sinus node artery  up to 310 nM 
3.1 µM 
unchanged heart rate 
bradycardia (immediate slowing by 26 beats/min) 
[38]  dog 
 
cat 
i.v. 
 
i.v. 
5 µg/kg 
 
7 µg/kg 
bradycardia of sinoatrial origin, decrease in 
conduction, hypotension 
respiratory arrest, no change or decrease in heart 
rate, hypotension 
[35]  cat 
cat, dog 
i.p. 
i.v. 
1 µg/kg daily 
5 µg/kg 
no pathological change 
rapid fall in blood pressure, cessation of 
respiration, bradycardia, no significant ECG 
abnormalities, reduced contractile force 
[36]  dog 
 
cat 
 
rabbit 
i.v. 
 
i.v. 
 
isolated heart 
5 µg/kg 
 
5 µg/kg 
 
~100 nM 
no significant ECG abnormalities, reduced 
contractile force, hypotension 
respiratory arrest, bradycardia at otherwise 
unchanged ECG, hypotension 
no significant effect 
[46]  rat  i.v.  5 µg/kg  sharp fall of blood pressure at initially unchanged 
heart rate and stroke volume 
 Mar. Drugs 2010, 8                 
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Table 2. Cont. 
[43]  rat  i.v. 
 
2.5 µg/kg 
 
10–40 µg/kg 
 
 
 
80 µg/kg 
unchanged blood flow in the ascending aorta, hypotension and 
bradycardia at otherwise unchanged ECG 
dose-related reduction of blood flow in the ascending aorta, 
bradycardia appeared unrelated to the size of the TTX dose, 
first degree AV block, bundle brunch block, ventricular 
flutter/fibrillation 
ventricular asystole 
 [43]  pithed 
rat 
i.v.  10–20 µg/kg  reduction of blood flow in the ascending aorta, hypotension, 
transient mild bradycardia, transient first degree AV block, 
bundle brunch block 
[43]  rat  isolated 
heart 
1.0 to 4.0 µg 
(3 µM solution) 
dissociation/cessation of ventricular contractions depending on 
dose 
[37]  cat  i.v.  1 µg/kg 
2.5–10 µg/kg 
unchanged heart rate, hypotension 
bradycardia, hypotension, slight PR prolongation, unchanged 
QS interval, reduced left ventricular force and reduced stroke 
volume 
[39]  cat  i.v.  1 µg/kg  unchanged heart rate, hypotension due to a direct relaxing 
effect on vascular smooth muscles 
[49]  cat  i.v.  1.4–3 µg/kg  prompt fall of blood pressure at unchanged heart rate and pulse 
pressure; initially no striking ECG alterations, increased 
amplitude of QRS and T wave after the development of 
hypotension 
[45]  guinea 
pig 
i.p.  15 µg/kg  response before respiratory arrest (≤10.3 min from injection 
time point): decline in blood pressure, but no change in heart 
rate and ECG waveform 
cardiac response shortly after respiratory arrest: paroxysmal 
ventricular tachycardia, sinus bradycardia, AV block 
[48]  rat  i.a.  20 µg/kg  rapid and severe hypotension, bradycardia, heart rate increased 
shortly after artificial respiration was commenced 
[44]  dog  i.v. 
(slowly) 
9.3 µg/kg/hr  at apnoe: bradycardia at unchanged stroke volume, 
hypotension, decreased total peripheral resistance, increased 
pulmonary vascular resistance and increased pulmonary arterial 
pressure; at higher TTX concentrations (12–20 µg/kg/hr), dogs 
died before or shortly after apnoe, which was due to fatal 
hypotension 
3.2. Bradycardia 
Slowing of the heart rate may also contribute to hypotension. However, administration of small  
sub-lethal doses produced hypotension only, and apparent changes of heart rate were rarely seen. TTX 
in doses of 0.1–0.3 MLD, corresponding to about 16–47 nM in the whole body's extracellular fluid, 
did not cause bradycardia in the cat, despite a prompt and marked fall in blood   Mar. Drugs 2010, 8                 
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pressure [37–39,49]. For example, Kao et al. demonstrated that the carotid blood pressure in cats can 
be reduced by i.v. injection of 2–3 µg/kg from 140/110 to 80/50 within two to three minutes, without 
affecting heart rate [41]. In some studies, even lethal doses of 7–10 µg/kg did not significantly alter 
heart rate in cats [38]. When heart rate reduction was measured, it often occurred subsequent to the 
onset of hypotension [38,40,45,46]. Severely intoxicated guinea pigs (15 µg/kg, i.p.) showed no signs 
of ECG alterations shortly before respiratory failure and death, despite a substantial drop in blood 
pressure [45]. In pithed rats, heart rate fell about 10% after injection of 1–2 MLD, but also soon 
regained the pre-injection state, in contrast to the long-lasting blood pressure reduction [43]. In another 
study, a 30–40% reduction in heart rate was observed in intoxicated rats (20 µg/kg). A few minutes 
after artificial respiration was commenced heart rate increased by 20%, but blood pressure further 
declined [48]. Altogether, these data indicate that bradycardia is not the primary cause of hypotension, 
although it may contribute to some extent to a reduced arterial blood pressure, in particular in severe 
cases of TTX intoxication. 
Concerning the mechanism behind the observed bradycardic effect, one can exclude a primary 
chronotropic effect via blockade of cardiac TTXs Na
+ channels: Firstly, direct application of a highly 
concentrated pufferfish solution or a toxin powder on the sinus node had no effect on the heart rate 
[27]. Secondly, Tomlinson and James [47] injected a volume of 2 ml of a 310 nM solution rapidly into 
the sinus node artery of dogs in order to avoid profound extracardiac effects of systemically applied 
TTX. The authors noticed that heart rate and rhythm remained constant. Only a 10-fold higher 
concentration caused a negative chronotropic effect (see below). Thirdly, sympathetic denervation of 
the cat heart resulted in a fall in heart rate to ~42–71%, but the subsequent application of a relatively 
high toxin dose (15 µg/kg) did not further decrease the heart rate [37]. Fourthly, the same lethal TTX 
dose of 15 µg/kg was rapidly injected as a bolus intraperitoneally into guinea pigs [45]. The authors 
noticed a decline in blood pressure, but even several minutes after intoxication, a regular heart rate and 
no change of the ECG wave form. ECG alterations indicative of paroxysmal ventricular tachycardia, 
sinus bradycardia and atrioventricular (AV) block emerged only after a complete cessation of 
respiratory movement and the substantial drop in arterial O2 (see also Section 4). Fifthly, TTXs Na
+ 
currents do not contribute to normal automaticity in isolated adult sinus node cells, as recently shown 
by Protas and co-workers [34]. The authors demonstrated that Na
+ current density in the canine sinus 
node decreases with age and that TTXs Na
+ channels are not available at physiological potentials [34]. 
Application of 100 nM TTX did neither change cycle length nor action potential parameters of adult 
sinus node cells. Consequently, TTXs Na
+ channels are present in the sinus node, but they do not exert 
a physiological function under normal conditions [34]. This conclusion is in agreement with   
previous data [50]. 
The transient or permanent reduction of the heart rate is most likely the result of a complex 
systemic reaction to TTX intoxication. There are several parameters that interfere with a normal heart 
beat in intoxicated mammals, like (a) a diminished pressoreflex despite hypotension, due to blockade 
of respective afferent and efferent nerve fibers, (b) a reduced venous return, due to massive 
vasodilatation and hypotension [39], (c) uncertain effects of respiratory irregularities on medullary 
cardiovascular centers normally involved in respiratory sinus arrhythmia, (d) direct effects of TTX on 
medullary neurons [26,35,40,45], or (e) block of sympathetic nerve fibers [37]. In particular the latter 
effect seems to play a predominant role in TTX-induced bradycardia [37], because in isolated Mar. Drugs 2010, 8                 
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sympathetic nerve-right atrium preparations, TTX at low concentrations (30–60 nM) abolished 
positive inotropic and chronotropic responses to nerve stimulation without any effect on spontaneous 
rate or force. 
At very high TTX doses of at least 1 MLD, the toxin has a direct cardiac effect [26,27,43], most 
likely  via blocking an increasingly number of Nav1.5 channels, leading to sinus bradycardia and 
conduction disturbances (see Section 3.4). This conclusion is supported by the following observations. 
Firstly, bradycardia was induced only when injecting a TTX solution of 3 µM into the canine sinus 
node artery (see above) [47]. Similar data at 3 µM TTX were observed using isolated rabbit atrial 
muscle strips including the sinus node [51]. Notably, sinus node action potentials were retained even at 
a concentration of up to 30 µM, which is far in excess of what is necessary to block conduction of 
nerve and skeletal muscle [51]. Secondly, very similar symptoms, i.e., sinus bradycardia and/or 
sinoatrial block, are observed in familial SSS, a well-recognised loss-of-function SCN5A 
channelopathy [7]. Recently, Verkerk and co-workers even succeeded in demonstrating a large Na
+ 
inward current in human sinoatrial node cells at resting potentials negative to -60 mV [52]. Although 
the molecular nature of this current could not be elucidated in detail, the pronounced hyperpolarized 
closed-state inactivation clearly points to Nav1.5 channels. And thirdly, heterozygous Scn5a
+/- mice 
showed depressed heart rates and occasionally sinoatrial block [53], implicating an important role of 
the normal cardiac Na
+ channel, Nav1.5, for pacemaker rates and sinus node conduction.  
3.3. Stoke volume reduction 
A reduced contractile force at low TTX concentrations has been suggested for Langendorff-
perfused mouse and guinea pig hearts [11]. Consequently, a resulting decline in stroke volume should 
be visible in intoxicated animals, and this decline should contribute to hypotension. 
However, unchanged stroke volumes were observed in independent studies, when sub-lethal or, 
depending on the application method, even lethal TTX doses were applied. For example, an unchanged 
blood flow in the ascending aorta of rats was observed, when injecting a sub-lethal dose of 2.5 µg/kg 
into the right external jugular vein. At this dose, arterial blood pressure was reduced from 120–150 to 
40–55 mmHg [43]. In a similar study, injection of 5 µg/kg caused a rapid fall in blood pressure at an 
initially unchanged heart rate and stroke volume [46]. Furthermore, slow intravenous TTX injections 
of 9.3 µg/kg, a lethal dose for dogs, did not alter the cardiac index until respiratory arrest [44]. At 
apnoea, the authors reported blood pressure reduction and decline in heart rate at an unchanged stroke 
volume. Using isolated perfused rat hearts, the TTX-containing blue-ringed octopus venom caused 
even a marked increase in ventricular contraction tension [48], although this effect could be caused by 
other compounds in the toxin extract. 
In some studies, a reduced contractile force was observed upon TTX intoxication [35–37,43]. The 
apparent negative inotropic action of TTX was discussed as the result of three different mechanisms:  
(a) blockade of excitability of central and/or peripheral nerve fibres at nanomolar concentrations, 
preventing neurogenic catecholamine release [35–37,41,43], (b) a direct negative inotropic effect 
occurring at micromolar concentrations in association with the reduction of the maximum rate of 
depolarization of the ventricular action potential, an effect that was not seen at 30 to 120 nM TTX 
[43,54–56], and (c) reduced cardiac output when marked peripheral vasodilatation caused a reduction Mar. Drugs 2010, 8                 
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in venous return [39,46]. The latter mechanism is probably the most important one, because 
hypotension occurred often sooner than cardiac depression [38]. Moreover, compression of the 
abdominal aorta as well as volume expansion normalized arterial blood pressure and cardiac 
performance instantaneously [26,27,39,41]. 
3.4. Cardiac conduction disturbances 
ECG alterations indicative of cardiac conduction abnormalities were observed rarely at sub-lethal 
doses of TTX (Table 2). Only slight PR prolongations were observed in cats and dogs when injecting  
2.5–10 µg/kg [37,38]. In other studies, ECG alterations were not seen in the same species at similar 
toxin concentrations [35,36,43,49]. In guinea pigs, the ECG waveform remained unchanged even 
minutes after injecting a high lethal toxin dose (15 µg/kg) [45]. 
Already in their early reports on the systemic effect of TTX, the Japanese researchers noticed 
conduction abnormalities in severely intoxicated animals, particularly after the cessation of respiration 
[26,27]. Severe TTX intoxication, which is typically characterized by cyanosis, areflexia, apnoea and 
hypotension, often triggered second or third degree AV block. In many intoxicated animals, 
ventricular contractions appeared regular, but at a lower frequency than those of the atria. Subsequent 
to complete AV block, ventricles stopped beating, but atria not. In one case, Takahashi and Inoko 
found atrial contractions that persisted even after the onset of rigor mortis [26]. Although it seems that 
these previous reports are a little antiquated, basically similar results were observed tens of years later 
using advanced techniques [37,43,45,57]. High lethal TTX doses (1–4 MLD) often caused conduction 
irregularities such as lengthening of the AV interval, true AV dissociation, bundle brunch block, 
ventricular flutter or fibrillation. Ventricular asystole was noticed when rapidly injecting a dose of  
8 MLD in rats [43].  
Conduction disturbances in severely intoxicated animals were most likely due to two mechanisms: 
(a) blockade of a significant portion of cardiac Nav1.5 channels, and (b) insufficient oxygen supply. 
The first conclusion is supported by the observation that conduction abnormalities were often 
associated with SCN5A channelopathies, like isolated CCD or LQT3 [6]. Moreover, Scn5a
+/- mice 
showed impaired AV conduction [58]. The second conclusion is supported by the fact that AV 
conduction block or paroxysmal ventricular tachycardia was observed subsequent to respiratory arrest 
and to the onset of hypoxia [26,45].  
According to a previous report [17], one should expect that the Purkinje fibers are the cardiac 
structures that respond most rapidly to TTX treatment with a diminished function. However, it is 
interesting to note that the AV node is obviously most susceptible to TTX. Yoo and colleagues 
precisely studied Nav1.5 expression in different regions of the AV node [59]. Nav1.5 labeling was 
absent in the open node, but present at a relatively low level in the pathways into the open node 
(inferior nodal extension and transitional zone). This suggests that the reduced expression of Nav1.5 
already diminishes the safety factor for conduction, and consequently, TTX selectively aggravates 
conduction in this AV nodal region. 
Other ECG changes were rarely reported. Some authors noticed T-wave alterations, like a non-
specific T wave reversal [38], the disappearance of the T wave [27], or an increase in amplitude [49]. 
Reasons for these phenomena are unknown. Kao and Fuhrman suggested an involvement of the Mar. Drugs 2010, 8                 
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adrenal medulla in intoxicated animals, and consequently, an indirect effect on the heart of circulating 
catecholamines [49]. In another study, a decrease in P wave at a relatively large sub-lethal dose of  
5 µg/kg was found in dogs [38]. 
4. Human Tetrodotoxication 
4.1. Epidemiology, symptoms, and prognosis 
TTX is one of the most potent, non-protein poisons known to man. It has been detected not only in 
many pufferfish species, but also in a wide variety of other animals, including the blue-ringed octopus, 
newts, gobies, frogs, worms, starfish, horseshoe crab, gastropods, and in several marine 
microorganisms, that produce and accumulate the toxin [60,61]. In the pufferfish body, TTX 
concentration and distribution depend on the species. Ovary, liver and skin usually contain highest 
TTX concentrations [60].  
Despite, or maybe even because of its severe toxicity, pufferfish is a speciality in Japan. The fish, 
also known as "fugu", is normally prepared by licensed puffer cooks, making the (expensive!) meals a 
culinary adventure, rather than a hazardous Russian roulette. Pufferfish poisoning or tetrodotoxication 
is, however, still one of the most common food poisonings along the coast of Asia. Ingestion of the 
toxic fish can be intentional or inadvertent. In Japan, it may happen by eating homemade liver dishes 
prepared from self-caught pufferfishes. In Bangladesh, several outbreaks of TTX poisoning with 
dozens of victims were reported, which occurred after pufferfishes (called “potka” fish) were available 
at local markets at a very cheap price [62–64]. Emergency physicians in Southern Europe should also 
be aware of the typical intoxication symptoms. Probably due to climate change and rising water 
temperatures, the toxin has approached the Portuguese coast, and caused recently the first case of 
tetrodotoxication in Europe (intoxication by a trumpet shellfish species) [65,66]. 
There is a long history of TTX intoxication. The first Europeans severely intoxicated were Captain 
Cook and his naturalists, J.R. and G. Forster. They enjoyed a pufferfish dinner, survived, and precisely 
described their symptoms [67]. Many case reports were known until 1941, when Fukuda and Tani 
provided a clinical grading system for TTX poisoning [61,68]. This four-degree classification is based 
on symptoms and stages of progression, and is still of clinical value (Table 3). The degree of 
intoxication actually depends on three factors: the TTX amount ingested, the time until admission to 
the emergency department, and pre-existing diseases (see below). First-degree and second-degree 
cases are relatively mild cases of tetrodotoxication (Table 3). There is a diminution or loss of some 
neuromuscular and neurological functions, but reflexes are still intact. The third degree is 
characterized by more severe disturbances, like ataxia, widespread paralysis, pronounced hyporeflexia, 
drop in blood pressure, fixed/dilated pupils, cyanosis, and respiratory failure (e.g., dyspnoea, decreased 
vital capacity or lower forced expiratory volume). Hypothermia also develops, when skeletal muscle 
contractions and conduction in nerve fibers are gradually blocked. Fourth-degree cases are severely 
intoxicated victims presenting with cessation of respiration, decreased arterial O2, unconsciousness, 
bradycardia, and hypotension. Severe cardiac manifestations, like conduction block or ventricular 
asystole, occurred when extremely high levels of TTX were ingested and as a late sign in fourth-
degree intoxicated patients [68–70]. Mar. Drugs 2010, 8                 
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Table 3. Clinical grading system in tetrodotoxication according to [68]. 
Degree  Symptoms 
First  Oral numbness and paraesthesia, sometimes accompanied by gastrointestinal symptoms (nausea
a)) 
Second  Numbness of face and other areas, advanced paraesthesia, motor paralysis of extremities, 
incoordination, slurred speech, but still normal reflexes 
Third  Gross muscular incoordination, aphonia, dysphagia, dyspnoea, cyanosis, drop in blood pressure, 
fixed/dilated pupils, precordial pain, but victims are still conscious 
Fourth  Severe respiratory failure and hypoxia, severe hypotension, bradycardia, cardiac arrhythmia, heart 
continues to pulsate for a short period 
(a) TTX is considered as the most potent emetic agent, directly acting on the medullary chemoreceptor   
trigger zone [41,70]. 
 
Tetrodotoxication can be rapidly fatal, and antidotes do not exist. Death may occur in as little as  
17 minutes after ingesting the toxin [71,72]. The human killing dose is assumed to be 1–2 mg 
[61,72,73]. Treatment is entirely supportive and may involve mechanical ventilation for oxygen 
supply, normal saline infusion for distending the intravascular volume, gastric emptying procedures, 
application of activated charcoal, atropinization, or treatment with dopamine. Cholinesterase inhibitors 
and other drugs have been suggested, but not tested adequately [69,70,74]. Prognosis is good if the 
patient arrives at the emergency department conscious and prior to respiratory arrest, and if the patient 
survives the first 24 hours. Symptoms usually resolve over a period of 24 hours to five days   
[64,65,75–77]. Early diagnosis and prompt clinical management essentially contribute to low mortality 
rates. In Japan, the fatality rate fell from 80% at the beginning of the last century, with more than  
100 deaths per year, to about 6% in the 90s [41,60,61]. In other Asian countries, mortality rates 
between 2–22% were reported recently [62–64,75]. 
In contrast to the in vitro assays (see 2) and in vivo animal experimentations (see 3), when 
crystalline TTX was used, human tetrodotoxication occurs by ingesting TTX-containing food. It is 
possible that this crude or combined TTX is more easily absorbed in the digestive tract. A respective 
crude TTX dose of as little as 20 µg/kg can be lethal for humans. However, feeding cats with a 10-fold 
higher dose of crystalline TTX (200 µg/kg) did not kill them, although an i.v. or i.p. injection of  
10 µg/kg was lethal [35]. Furthermore, it is possible that the toxin-containing food exerts slightly 
different effects in the human body, when compared to those observed after injecting a highly purified 
TTX solution into animals. Some marine species may produce and accumulate also smaller quantities 
of TTX analogs, or possibly even other toxic compounds, so that the symptoms may not always be 
solely due to authentic TTX [66]. 
4.2. Correlation between blood TTX levels and intoxication symptoms 
Electrophysiological recordings demonstrated an IC50 of about 10 nM for TTXs Na
+ channels [2]. 
In order to compare this in vitro TTX sensitivity with blood levels in patients, and to correlate the in 
vivo TTX concentrations with the symptoms, all currently available blood concentrations were plotted Mar. Drugs 2010, 8                 
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against the intoxication grade of the corresponding patients (Figure 1; for values see Table 4). In less 
severely intoxicated patients (first and second degree), blood levels were similar to or lower than the 
IC50 of TTXs Na
+ channels. In severe cases of intoxication (fourth degree in Figure 1), TTX 
concentrations of 40–164 nM were observed. The calculated average concentration of   
88 ± 22 nM (n = 5) would be indeed high enough to block the vast majority of TTXs Na
+ channels in 
the body.  
Figure 1. TTX concentrations in blood or serum samples of intoxicated patients. The 
degree of intoxication was either reported by the authors or assessed according to 
documented symptoms (for individual data points see Table 4 and the respective 
references). The lowest and highest concentration reported in [62] was assigned to the first 
and fourth stage, respectively. Patients 4, 2, 3, and 1, previously reported in [76,81] were 
assigned to the first, second, third, and fourth stage, respectively. A value of 80 nM was 
assumed for a severely intoxicated patient whose serum and blood levels were about 83 
and 77 nM, respectively [65,66]. 
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Unfortunately, a precise correlation between the biological activity of an ingested TTX bolus and 
the clinical symptoms is currently difficult to establish, because blood concentrations in victims were 
rarely determined. It is likely that the effective TTX concentration in the heart is higher than the values 
reported. All TTX concentrations were determined from "spot" samples taken during the first day of 
hospitalization. Peak concentrations were probably missed in some cases. Moreover, serum levels may 
not necessarily indicate the effective concentration in an organ. TTX is rapidly absorbed in the human 
digestive tract, but it remains in the serum compartment only for a relatively short period (less than  
24 h). From day two of hospitalization, TTX serum levels were below the detection limit in severe 
intoxicated patients [78,79], but TTX appeared in the urine until day four [78]. During this time, 
intoxication symptoms persisted and mechanical ventilation was still required [79]. It seems that TTX 
is rapidly eliminated from the serum not only by excretion in the kidney, but also via an efficient 
binding to the TTX receptors. Thus, the toxin may accumulate in an excitable tissue. As suggested by 
O'Leary and colleagues [80], elimination of TTX from the body requires unbinding from Na
+ channels 
and redistribution to the serum. This could be the rate-limiting step in the elimination of TTX from the 
body. The idea that TTX accumulates in organs with TTX binding sites is supported by previous work Mar. Drugs 2010, 8                 
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of Ogura who detected high TTX levels in whole heart and kidney (excretion), and lowest 
concentrations in brain and blood [41,42]. Low levels in the brain suggest a limited ability of TTX to 
cross the human blood-brain barrier. In this context it is interesting to note that victims often remain 
conscious, but cannot speak, move or breathe. 
4.3. Cardiac excitation and performance in intoxicated patients 
Cardiac dysrhythmias, like AV node conduction abnormalities, bundle-brunch block, tachycardia, 
or even ventricular stoppage were previously reported to occur in some severely intoxicated patients 
[68,69]. Because a lethal dose of about 2 mg TTX is unlikely to result in serum concentrations 
significantly higher than 200 nM, blocking cardiac TTXs Na
+ channels, rather than blocking Nav1.5, 
could contribute to these cardiac dysrhythmias. However, cardiac excitation abnormalities may not 
causally depend on a direct action of TTX on cardiomyocytes, but mainly on oxygen limitation 
resulting from respiratory arrest. If the latter assumption is true, cardiac dysrhythmias in severely 
intoxicated victims should have been observed rarely during the last 25 years, because of the high 
standard of modern medicine and the prompt availability of a mechanical ventilation device when 
respiratory arrest is imminent. 
To prove this assumption, a literature screening for reports on outbreaks and cases of 
tetrodotoxication between 1983 and 2009 was performed (Table 4). Particular attention was paid to 
cardiovascular effects in victims. Table 4 represents a summary of several representative reports, but 
not a complete catalog of all cases of tetrodotoxication. In those 20 studies, more than 500 cases of 
tetrodotoxication were reported. Notably, all patients were admitted to an emergency department or an 
intensive care unit. However, the cardiovascular status, including blood pressure or ECG, was often 
not explicitly mentioned, despite an accurate description of neurological and neuromuscular symptoms.  
The overall mortality rate during this 27-year period was about 6.6% (34 fatal cases). Hypotension 
was reported in 22 cases (4.2%). Blood pressure reduction was usually accompanied by rather severe 
other symptoms, like respiratory arrest or block of nerve conduction. Among fourth-degree cases, only 
20.6% of the patients developed hypotension, as documented in [75]. Sinus bradycardia was 
mentioned only in seven cases, and two of those patients had a pre-existing chronic disease (diabetes 
mellitus). Surprisingly, AV block was diagnosed only in one patient, who experienced cardiac arrest 
before arriving at the emergency department and who also had diabetes mellitus [76]. No other 
pathological ECG signs, like bundle brunch block or ventricular arrhythmias, were reported (Table 4). 
Even severely intoxicated patients, i.e., fourth-degree victims, presented with a stable cardiovascular 
status, when they were successfully resuscitated or when oxygen supply was rapidly provided by 
artificial ventilation [65,89]. In a recent case report, the patient's serum contained nearly 80 nM TTX, 
which was shown to be high enough to completely block nerve conduction [65]. At the same time, 
heart rate and blood pressure were normal, and cardiac conduction disturbances were not observed 
[65]. The authors concluded that cardiac arrhythmias or cardiac arrest, as observed for example in [85], 
were due to hypoxemia secondary to respiratory muscle paralysis [65]. Higher blood concentrations of 
114 nM were observed in another patient that developed bradycardia and hypotension, but no cardiac 
conduction abnormalities were noted [78]. More severe symptoms and poor prognosis were reported 
for victims with a pre-existing disease, in particular for diabetes mellitus patients [76,83]. The reasons Mar. Drugs 2010, 8                 
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are unknown, but there could be a synergistic effect of diabetic neuropathy and TTXs Na
+ channel 
blockade on nerve and skeletal muscle excitability [76]. 
Table 4. Summary on case reports between 1983 and 2009 on TTX-poisoned patients. 
Study  Cases  Grade 
TTX 
(nM)
a) 
Hypo-
tension 
Sinus 
brady-
cardia 
ECG 
Artificial 
respiration 
Comments 
[82]  3  1–2    no  no    no  oxygen saturation 96–99% 
[76,81]  4  1–2  4.5–21.1  no or mild  no  normal  no  mild hypercapnia 
[83]  16  1–2          no  eight patients had hypertension 
[84]  3  1–2    no      no   
[75]  177  1–3    no      no  all recovered completely 
[85]  6  1–3          no   
[70]  1  2–3    yes  yes  normal
b)  no  hypoxemia, diabetes mellitus
c) 
[74]  1  2–3    no  no    no  normal arterial pO2 
[86]  4  2–3    no  inter-
mittent
d) 
normal  no  normal blood pressure, no hypoxia 
[77,80]  11  2–3  <5–5 
(grade 2) 
no  no    yes 
(grade 3) 
no cardiovascular effects, no fatalities 
[87]  1  3    no  yes  normal  yes  reduced sensory and motor conduction velocities, 
decrease in evoked amplitudes 
[88]  1  3    no  no  normal  yes  decreased arterial pO2 
[76,81]  1  3  28.6  yes  no  normal  yes   
[83]  1  3–4    hyper-
tension
c) 
no    Yes (cyanosis)  diabetes mellitus
c), renal failure and death 
(intoxication by molluscs) 
[89]  1  4          yes  stable cardiovascular status after cardiopulmonary 
resuscitation; TTX-induced cranial diabetes 
insipidus 
[65,66]  1  4  77/83  no  no  normal  yes  non-excitability of sensory and motor nerves 
[85]  1  4    yes  no    yes  cardiac arrest before admission to the ED, 
resuscitation to sinus rhythm, patient died 
[76,81]  1  4  40.6  yes  yes  AV block  yes  diabetes mellitus
c), full cardiac arrest, spontaneous 
circulation after resuscitation, but patient died due 
to multi-organ failure 
[78]  1  4  114  yes  yes  normal  yes  hypothermia, blood gases were unremarkable 
[79]  1  4  164  yes      yes  complete block of motor nerve conduction 
[75]  68  4    Yes 
(14/68) 
    Yes (all)  five fatalities, one patient with brain damage 
[62]  83  1–4  5–43 
e)          seven fatal cases (respiratory arrest) 
[63]  37  1–4            eight fatalities 
[64]  53  1–4            eight fatalities 
[90]  40  1–4            no fatalities 
(a) Reported TTX concentrations in serum or blood samples. 
(b) mild ST elevation. 
(c) pre-existing disease. 
(d) Cardiac dysautonomia did 
not correlate to TTX levels in blood [86]. 
(e) TTX concentrations were determined in blood or urine from 38 patients [62]. Mar. Drugs 2010, 8                 
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It is interesting to note that cardiovascular manifestations, like hypotension and sinus bradycardia, 
cannot be considered as general accompanying symptoms in severely intoxicated and mechanically 
ventilated patients [65,88,89]. Some patients even presented with hypertension [83]. If TTXs Na
+ 
channels increase the spontaneous heart rate and improve the contractile force under normal 
physiological conditions, their blockade by TTX would result in a decreased cardiac output. In order to 
maintain (or increase) the arterial blood pressure, such a cardio-depressive effect must be counteracted 
by an increased vasomotor tone. This scenario is very unlikely to occur when conduction in 
sympathetic fibers is partially or completely blocked. The TPR in TTX-poisoned patients was not yet 
determined. However, TTX should produce vasodilatation instead of vasoconstriction, and 
hypotension can be sufficiently explained by a reduced vasomotor tone (see 3).  
The heart beat was regular, also when sinus bradycardia was noted [70,87]. In another study, an 
intermittent sinus bradycardia was reported [86]. The occurrence of cardiac dysautonomia, i.e., 
transient increases and decreases in heart rate, did not correlate with the TTX levels [86]. As discussed 
by the authors, the phenomenon of intermittent sinus bradycardia is likely due to TTX-mediated 
imbalances between the parasympathetic and sympathetic nervous system [86].  
In conclusion, severe neurological and neuromuscular symptoms in third-degree and fourth-degree 
intoxicated victims strongly suggest that a significant portion of functional TTXs Na
+ channels was 
blocked. Except for one patient, who experienced cardiac arrest before admission to the emergency 
department, ECG abnormalities, indicative of cardiac arrhythmias like SA block, AV block, bundle 
brunch block or ventricular tachycardia/fibrillation, were not reported to occur during treatment of the 
patients in an emergency department or intensive care unit. This strongly suggests that cardiac 
excitation is not significantly impaired in intoxicated victims with relatively high TTX blood levels, as 
long as sufficient oxygen is provided. 
5. Conclusions 
This review on the systemic effects of TTX is not the first account suggesting that Nav1.5 is the 
only functional voltage-gated Na
+ channel in the adult, non-diseased myocardium of higher mammals. 
The clinical data are in close agreement with results from animal experiments, a conclusion that was 
already drawn as early as in the 19th century [26]. Altogether, these data argue against a physiological 
function of cardiac TTXs Na
+ channels in higher mammals. This conclusion is strongly supported also 
by several biochemical and electrophysiological studies, demonstrating (a) Nav1.5 in all plasma 
membrane regions of ventricular cardiomyocytes [18,23,91], (b) only minute quantities of transcripts 
for TTXs Na
+ channels in the whole human heart [4,5], (c) inactivated TTXs Na
+ channels in the sinus 
node at normal membrane potentials [34,50], (d) unchanged conduction in Purkinje fibers at low TTX 
concentrations [92,93], and (e) no contribution of TTXs Na
+ channels to excitation-contraction 
coupling [94]. Mar. Drugs 2010, 8                 
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